Search
Descriptor English: Drug Resistance, Neoplasm
Descriptor Spanish: Resistencia a Antineoplásicos
Descriptor resistencia a los antineoplásicos
Entry term(s) resistencia a antineoplásicos
resistencia a la quimioterapia
Scope note: Resistencia o respuesta disminuida de una neoplasia a un fármaco antineoplásico en seres humanos, animales, células o cultivos de tejidos.
Descriptor Portuguese: Resistencia a Medicamentos Antineoplásicos
Descriptor French: Résistance aux médicaments antinéoplasiques
Entry term(s): Antibiotic Resistance, Neoplasm
Antineoplastic Agent Resistance
Antineoplastic Drug Resistance
Drug Resistance, Antineoplastic
Neoplasm Drug Resistance
Resistance, Antineoplastic Agent
Resistance, Antineoplastic Drug
Tree number(s): G07.690.773.984.395
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D019008
Scope note: Resistance or diminished response of a neoplasm to an antineoplastic agent in humans, animals, or cell or tissue cultures.
Allowable Qualifiers: DE drug effects
GE genetics
IM immunology
PH physiology
RE radiation effects
Previous Indexing: Drug Resistance (1972-1995)
Public MeSH Note: 96
History Note: 96
Entry Version: DRUG RESISTANCE NEOPL
DeCS ID: 32769
Unique ID: D019008
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1996/01/01
Date of Entry: 1995/05/24
Revision Date: 2015/06/29
Drug Resistance, Neoplasm - Preferred
Concept UI M0028386
Scope note Resistance or diminished response of a neoplasm to an antineoplastic agent in humans, animals, or cell or tissue cultures.
Preferred term Drug Resistance, Neoplasm
Entry term(s) Antineoplastic Agent Resistance
Antineoplastic Drug Resistance
Drug Resistance, Antineoplastic
Neoplasm Drug Resistance
Resistance, Antineoplastic Agent
Resistance, Antineoplastic Drug
Antibiotic Resistance, Neoplasm - Narrower
Concept UI M0377179
Preferred term Antibiotic Resistance, Neoplasm



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.


Go to survey